Rosebank Industries raises £1.14 billion in capital

Rosebank Industries PLC has successfully raised £1.14 billion through an institutional capital raise, issuing 380 million new ordinary shares at £3.00 per share, to fund the acquisition of ECI, a U.S.-based electrical distribution systems company. Trading of Rosebank's shares remains suspended until the admission document is published around June 11, 2025, with new shares expected to be admitted to trading on July 3, 2025, pending shareholder approval. The acquisition, part of Rosebank's "Buy, Improve, Sell" strategy, is projected to complete in Q3 2025 and involves related party transactions with BlackRock Inc. (NYSE:BLK).

Analysis

Rosebank Industries PLC has successfully completed a significant institutional capital raise of approximately £1.14 billion through the issuance of 380 million new ordinary shares priced at £3.00 per share, a development that has garnered strongly positive sentiment (overall score 0.75, Rosebank-specific 0.8). These funds are strategically designated to finance the acquisition of ECI, a U.S.-based private company specializing in critical electrical distribution systems, which aligns with Rosebank's articulated "Buy, Improve, Sell" strategy and will be funded by a combination of debt facilities and this new equity. Trading of Rosebank's existing ordinary shares on the AIM market remains suspended pending the publication of an admission document, expected around June 11, 2025. The new ordinary shares are anticipated to be admitted to trading on July 3, 2025, following shareholder approval of transaction resolutions at a general meeting scheduled for July 1, 2025. The completion of the ECI acquisition is projected for the third quarter of 2025, after which Rosebank plans to cancel the current admission of its ordinary shares and apply for readmission of the enlarged group. Rosebank's CEO, Simon Peckham, highlighted the acquisition's potential to enhance profitability and deliver strong returns, with substantial shareholder BlackRock Inc. participating in the capital raise under identical terms, and Investec Bank PLC, the company's nominated adviser, having deemed the capital raise terms fair and reasonable to shareholders.

Key Decisions for Investors

• Existing Rosebank shareholders should closely monitor communications regarding the general meeting on July 1, 2025, for the crucial transaction approval, and anticipate the admission document release around June 11, 2025, while noting the ongoing share trading suspension until the enlarged group's readmission.
• Prospective investors should assess the detailed financial and strategic information within the forthcoming admission document to evaluate the ECI acquisition's potential, recognizing that new shares are expected to commence trading on July 3, 2025, offering an entry point into the company's expanded operations.